BridgeMD
Compares treatment options for Neck Pain
Official title Active Release Versus Strain-Counter-strain Technique in Patients With Non-Specific Neck Pain
ClinicalTrials.gov ID: NCT07026006
What this study is testing
- What it's testing
- The study design will be a randomized clinical trial (RCT) aims to compare the effects of Active Release Technique and Strain-Counterstrain on pain, range of motion, cranio-vertebral angle, and disability in patients with non-specific neck pain. Data will be collected from Safi Teaching Hospital, Faisalabad, Pakistan.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45
You may be able to join if
- Age 18-45 years
- Both male and female
- Patients with neck pain for at least 2 months
- Palpable taut bands in upper trapezius, SCM
- ATrPs in upper trapezius, levator scapulae, SCM
You likely can't join if
- Myofascial treatment in the preceding month
- Diagnosis of fibromyalgia
- Congenital problems
- Trigger point injections
- Individuals with KNGF Clinical Practice Guideline Grade III and IV severity of neck pain
- Respiratory disease and joint disease
See the full eligibility criteria
- Age 18-45 years
- Both male and female
- Patients with neck pain for at least 2 months
- Palpable taut bands in upper trapezius, SCM
- ATrPs in upper trapezius, levator scapulae, SCM
- NPRS score is \>3/10 on NPRS for neck region
- Individuals with a Craniovertebral angle less than 53
- Individuals having grade 2 severity of neck pain according to KNGF Guidelines
- Localized pain/stiffness in cervical spine (C3-C7) without upper limb radiculopathy
- Diagnostic Tests: Negative Spurling's test, upper limb tension test, and shoulder abduction test
- Myofascial treatment in the preceding month
- Diagnosis of fibromyalgia
- Congenital problems
- Trigger point injections
- Individuals with KNGF Clinical Practice Guideline Grade III and IV severity of neck pain
- Respiratory disease and joint disease
- Neurological deficit
The study team makes the final eligibility decision.
Where it's taking place
- Lahore, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.